BioSpace News Archive

Commercially branded in China as DR MassARRAY by DaRui, the approval of the MALDI-TOF based system for targeted genetic analysis is the successful culmination of the commercial partnership that was initiated in 2016 between the two companies.

PYTG officially owns NxGen operations, brands, marketplace and is currently now a subsidiary of Pyramidion Technology Group, Inc.

65th Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP) taking place in Seattle, Washington, October 22 to 27, 2018.

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2018 financial results on Thursday, November 1, 2018 after the market closes.

BioLab Sciences, an innovator in regenerative medicine technologies, today announced its exclusively licensed technology for MyOwn SkinT

Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company, today announced that it will release its third-quarter 2018 financial and business results after market close on November 7, 2018.

“Ray has been working with us as an advisor for two years, and we are thrilled to have him join us full time as we expand our focus on biologics drug discovery,” said CEO Emily M. Leproust, Ph.D.

Next generation sequencing services (NGSS) identifying any plant pathogen

New patent claims strengthen patent estate revenue Aligns with Onvansertib Clinical Development and Biomarker Strategy in AML.

SRAXmd announced that Ben Waldshan has joined the company as Executive Chairman of the Board of Managers and Stacey Hafers has joined as Chief Financial Officer of the Company.